NDC codes

FDA NDC Directory
Product NDC (as listed)0615-8408Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00615-8408Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0615-8408-390061584083930 TABLET in 1 BLISTER PACK (0615-8408-39)Marketed from Oct 6, 2021

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Glipizide
Generic name (nonproprietary)
glipizide
Active ingredients
Glipizide — 10 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 074223
Marketing start
Listing expires
Other FDA classes
Sulfonylurea Compounds (Chemical structure)
Identifiers
Product ID 0615-8408_7d1ee79a-1187-4d20-a572-15989eddfe78SPL ID 7d1ee79a-1187-4d20-a572-15989eddfe78SPL set ID bf5ff427-3ee4-4064-a55e-35daa2f12a06RxCUI 310488, 310490UNII X7WDT95N5C
Pharmacologic class
Sulfonylurea

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400615840839 followed by a unit qualifier and the quantity

Package 00615-8408-39. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Glipizide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074223

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074223
ProductStrengthForm · routeLabelerProduct NDC
GlipizideGlipizide 10 mg/1TabletOralA-S Medication Solutions50090-6996
GlipizideGlipizide 5 mg/1TabletOralActavis Pharma, Inc.0591-0460
GlipizideGlipizide 5 mg/1TabletOralA-S Medication Solutions50090-7908
GlipizideGlipizide 5 mg/1TabletOralPreferred Pharmaceuticals Inc.68788-8512
GlipizideGlipizide 10 mg/1TabletOralPreferred Pharmaceuticals Inc..68788-8138
GlipizideGlipizide 10 mg/1TabletOralNuCare Pharmaceuticals,Inc.68071-4643
GlipizideGlipizide 5 mg/1TabletOralAphena Pharma Solutions - Tennessee, LLC43353-207
GlipizideGlipizide 5 mg/1TabletOralNCS HealthCare of KY, LLC dba Vangard Labs0615-8407
GlipizideGlipizide 5 mg/1TabletOralA-S Medication Solutions50090-6473
GlipizideGlipizide 10 mg/1TabletOralActavis Pharma, Inc.0591-0461
GlipizideGlipizide 5 mg/1TabletOralBryant Ranch Prepack63629-1398
GlipizideGlipizide 10 mg/1TabletOralProficient Rx LP63187-811
GlipizideGlipizide 5 mg/1TabletOralPD-Rx Pharmaceuticals, Inc.55289-806
GlipizideGlipizide 5 mg/1TabletOralNuCare Pharmaceuticals,Inc.68071-4085
GlipizideGlipizide 5 mg/1TabletOralNuCare Pharmaceuticals,Inc.68071-4939
GlipizideGlipizide 10 mg/1TabletOralNorthwind Health Company, LLC51655-810
GlipizideGlipizide 10 mg/1TabletOralNuCare Pharmaceuticals,Inc.68071-4124

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in